233 related articles for article (PubMed ID: 16720068)
1. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068
[TBL] [Abstract][Full Text] [Related]
2. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
3. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome secondary to quetiapine.
Gortney JS; Fagan A; Kissack JC
Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
[TBL] [Abstract][Full Text] [Related]
5. The treatment of depression with paroxetine in psychiatric practice in Germany: the possibilities and current limitations of drug monitoring.
Zaninelli R; Meister W
Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):9-20. PubMed ID: 9035223
[TBL] [Abstract][Full Text] [Related]
6. Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish.
Gallelli L; De Fazio S; Corace E; De Sarro G; Garcia CS; De Fazio P
Pharmacopsychiatry; 2006 Jul; 39(4):154-6. PubMed ID: 16871472
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
Norris B; Angeles V; Eisenstein R; Seale JP
Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106
[TBL] [Abstract][Full Text] [Related]
8. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
Vergouwen AC; Bakker A
Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
[TBL] [Abstract][Full Text] [Related]
9. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of extrapyramidal symptoms with paroxetine.
Arya DK; McKenzie J; Worrall N
Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
[No Abstract] [Full Text] [Related]
11. Induction of mania in depression by paroxetine.
Morishita S; Arita S
Hum Psychopharmacol; 2003 Oct; 18(7):565-8. PubMed ID: 14533140
[TBL] [Abstract][Full Text] [Related]
12. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Krol DG; Nolen WA
Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
[TBL] [Abstract][Full Text] [Related]
13. A case of serial nightmares and oneiroid state under paroxetine for senile depression.
Kobayashi T; Yamauchi M
Psychogeriatrics; 2012 Mar; 12(1):54-7. PubMed ID: 22416829
[TBL] [Abstract][Full Text] [Related]
14. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
Aruna AS; Murungi JH
Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
17. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome: a review and report of six cases.
Kasantikul D; Kanchanatawan B
J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
[TBL] [Abstract][Full Text] [Related]
19. [A case of probable neuroleptic malignant syndrome induced by monotherapy with paroxetine].
Nishimura H; Kashima N
Seishin Shinkeigaku Zasshi; 2004; 106(6):723-6. PubMed ID: 15387267
[No Abstract] [Full Text] [Related]
20. Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Erermis S; Bildik T; Tamar M; Gockay A; Karasoy H; Ercan ES
Clin Toxicol (Phila); 2007; 45(3):277-80. PubMed ID: 17453880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
